Rare diseases
Investigational molecules
Locations
Back to Germany67 clinical trials in Cottbus, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on the Effects of Dexpramipexole for Adolescents and Adults with Severe Eosinophilic Asthma
GermanyStudy on the Effectiveness and Safety of Fluticasone Propionate and Salbutamol Sulfate for Patients with Asthma
GermanyStudy on Adjuvant Therapy with Capecitabine for Stage II Colon and Rectal Cancer Patients with Positive ctDNA After Tumor Removal
GermanyStudy on Tafasitamab and Lenalidomide with Standard Therapy for Newly Diagnosed High-Risk Diffuse Large B-Cell Lymphoma Patients
GermanyStudy on the Effects of Itepekimab for Patients with Non-Cystic Fibrosis Bronchiectasis
GermanyStudy Comparing Teclistamab with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma After 1-3 Prior Treatments
GermanyStudy on Improving Treatment for Children and Adolescents with Acute Lymphoblastic Leukemia Using Bortezomib, Blinatumomab, and a Drug Combination
GermanyStudy on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Active Psoriatic Arthritis
GermanyStudy on Golcadomide and R-CHOP Drug Combination for Patients with Untreated High-risk Large B-cell Lymphoma
GermanyStudy of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer
GermanyStudy on the Effectiveness and Safety of Ranibizumab for Patients with Wet Age-Related Macular Degeneration Using a 36-Week Refill System
GermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on breast cancer treatments, including studies of abemaciclib and ribociclib in combination with endocrine therapy. Research also encompasses lymphoma and multiple myeloma treatments.
Advanced trials evaluating targeted therapies and immunotherapy approaches for various cancer types.
Comprehensive studies examining treatments for asthma and COPD, including evaluation of novel inhaler combinations and biological therapies.
Investigations into both maintenance therapies and acute treatment options for respiratory conditions.
Specialized research focusing on Mucopolysaccharidosis Type II (Hunter Syndrome) and other rare genetic conditions, evaluating novel therapeutic approaches.
Emphasis on developing treatments that can cross the blood-brain barrier and address both somatic and CNS symptoms.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
